Filter
2023
Filtered Results: 2023
Text search:
and
A.
Rouse
Featured
Recommendations
299
New Publications
410
Language
Document type
No document type
573
Guidelines
496
Studies & Reports
445
Manuals
258
Strategic & Response Plan
118
Training Material
71
Fact sheets
38
Infographics
8
Situation Updates
7
Resource Platforms
5
Brochures
3
Videos
1
Countries / Regions
Global
158
India
70
Latin America and the Carribbean
40
Kenya
33
Western and Central Europe
33
Liberia
32
South–East Asia Region
29
Ukraine
26
Sierra Leone
26
Nigeria
26
Africa
25
Rwanda
21
Eastern Europe and Central Asia
21
South Africa
20
Ethiopia
20
Ghana
17
Uganda
17
Myanmar / Burma
16
Philippines
15
Tanzania
14
Bangladesh
14
Syria
13
Nepal
12
Middle East and North Africa
12
Asia
11
West and Central Africa
11
South Sudan
11
Guinea
10
Congo, Democratic Republic of
10
East and Southern Africa
10
Western Pacific Region
9
Malawi
7
Haiti
7
Yemen
7
Afghanistan
6
Russia
6
Pakistan
6
Jordan
5
Sudan
5
Zambia
5
Somalia
5
Tajikistan
4
Thailand
4
Iran
4
Senegal
4
Cambodia
4
North America
4
Lebanon
4
Eastern Europe
4
Iraq
4
North Macedonia
3
Timor Leste/ East Timor
3
Cameroon
3
Burkina Faso
3
Mozambique
3
Venezuela
3
Côte d’Ivoire / Ivory Coast
3
Namibia
3
Egypt
3
Colombia
2
Lesotho
2
Turkey
2
Kazakhstan
2
Laos
2
Kyrgyzstan
2
Peru
2
Zimbabwe
2
USA
2
Saudi Arabia
2
Vietnam
2
Sri Lanka
2
Djibouti
2
Georgia
2
Mali
2
Botswana
2
Indonesia
2
Ecuador
2
Eswatini/ Swaziland
2
North Korea
1
Serbia
1
Benin
1
China
1
Chile
1
Albania
1
Singapore
1
Estonia
1
Uzbekistan
1
Morocco
1
Mongolia
1
Qatar
1
Bulgaria
1
Armenia
1
Germany
1
Ireland
1
Paraguay
1
Denmark
1
Mauritius
1
Tunisia
1
Azerbaijan
1
Belarus
1
French Guyana
1
Bolivia
1
Brazil
1
Greece
1
Palestine
1
Angola
1
Chad
1
Libya
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
426
Clinical Guidelines
264
Key Resources
191
Public Health
185
Women & Child Health
157
Capacity Building
66
Pharmacy & Technologies
59
Toolboxes
COVID-19
210
HIV
141
Mental Health
139
Caregiver
120
Planetary Health
120
TB
114
NTDs
97
AMR
87
Ebola & Marburg
83
Rapid Response
55
Pharmacy
55
Global Health Education
54
NCDs
50
2.0 Rapid Response
47
Malaria
46
Disability
41
Conflict
40
Natural Hazards
30
Health Financing Toolbox
25
Refugee
23
Cholera
14
Specific Hazards
9
Polio
8
Zika
7
Social Ethics
2
The recommendations cover the level of blood pressure to start medication, what type of medicine or combination of medicines to use, the target blood pressure level, and how often to have follow-up checks on blood pressure. In addition, the guideline provides the basis for how physicians and other h...
These WHO guidelines which were updated in 2018, are valid for any country and suitable to local adaptations, and take account of the strength of available scientific evidence, the cost and resource implications, and patient values and preferences.
The 2018 edition of the guidelines includes the re...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
Since 24 February 2022, the war in Ukraine has caused widespread suffering to its people and serious damage
to the country’s infrastructure. Attacks on the country’s health system and its power network threaten people, compromise the provision of health care, and complicate the distribution of ...
Module 9
Strategic planning
July 2017
Module 9: Strategic planning. As WHO recommends offering PrEP to people at substantial HIV risk, this module offers public health guidance for policy-makers on how to prioritize services, in order to reach those who could benefit most from PrEP, and in wh...
Trachoma is the leading infectious cause of blindness (2). It is characterized by repeated
conjunctival infection with particular strains of Chlamydia trachomatis. This scars the conjunctivae and,
in some cases, leads to trichiasis with or without entropion. The abrasive action of eyelashes can
d...
Update 2021; Immunization, Vaccines and Biologicals
This new guideline on non-clinical interventions to reduce unnecessary caesarean sections incorporates the views, fears and beliefs of both women and health professionals about caesarean sections. It also considers the complex dynamics and limitations of health systems and organizations and relation...
In 2015, 5.9 million children under age five died (1). The major causes of child deaths globally are pneumonia, prematurity, intrapartum-related complications, neonatal sepsis, congenital anomalies, diarrhoea, injuries and malaria (2). Most of these diseases and conditions are at least partially cau...
Guidelines on the management of chronic pain in children, developing and implementing national and local policies for pain management and protocols in children, implementing national and local regulations for pain management in children, pain management and protocols
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
Many of the countries in the European Region receiving refugees from Ukraine are already offering vaccination services to children and adults. This is important to mitigate the risk of COVID-19 transmission among people travelling or living in close quarters, to protect the refugees from diseases th...
This guideline provides evidence-informed guidance on the use of non-sugar sweeteners to reduce the risk of unhealthy weight gain and diet-related noncommunicable diseases in adults and children. The guidance in this guideline is not based on toxicological assessments of the safety of individual no...
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV; performing appropriate testing before initi...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
WHO’s antiretroviral treatment (ART) clinic-based acquired drug resistance survey method yields robust estimates of HIV viral suppression and acquired HIV drug resistance in adults, children and adolescents taking both dolutegravir and non-dolutegravir based regimens.
Results are used to inform A...
This document summarizes the results of the WHO-commissioned full value proposition for new tuberculosis (TB) vaccines. The assessment was commissioned to provide early evidence for national and global decision-makers involved in TB vaccine development and implementation, who include stakeholders in...
This study was carried out to better understand the local beliefs and practices likely to enhance or hinder efforts to respond to the Ebola Virus Disease outbreak in Liberia.
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot...
